PRME
Prime Medicine, Inc. · Healthcare
10% owner Gv 2019 Gp, L.L.C. sold $2.4M of Prime Medicine, Inc.
Sold$2,359,309
$12.74Price
185,242Shares
−1%Stake
What PRME did after the filing
- The stock from Tue, May 16 close, $12.56
- +18.2%
- S&P 500, same days
- +7.2%
Measured over 30 trading days, to the Jun 29 close.
Traded Fri, May 12. Filed Tue, May 16, 12:16 PM ET, during the session. Returns use the May 16 close and the Jun 29 close. Not investment advice.